BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard
X-ORIGINAL-URL:https://mrctcenter.org
X-WR-CALDESC:Events for The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261005T100000
DTEND;TZID=America/New_York:20261005T123000
DTSTAMP:20260926T212017
CREATED:20251002T185425Z
LAST-MODIFIED:20260824T020335Z
UID:24837-1791194400-1791203400@mrctcenter.org
SUMMARY:What’s Mine Is Mine and What’s Yours Is Mine: Data Ownership and Sovereignty 
DESCRIPTION:Topic: What’s Mine Is Mine and What’s Yours Is Mine: Data Ownership and Sovereignty \n\n\n\nAbstract: As big data and AI become more widespread\, concerns about data privacy and security have intensified\, with many countries restricting access to their citizens’ data (and\, in some settings\, to data stored in those countries\, regardless of citizenship). International ethical guidelines\, such as the Declaration of Taipei\, state that individuals are entitled to control the use of their personal data. But most people fail to appreciate how much of their data is already publicly available\, how much of their data they can no longer control\, and how extensive their digital footprint is. When they do learn\, individuals feel excluded from decisions about their information and express the desire to determine how their data is accessed and used. Are data ownership\, consent\, and permissions to control one’s existing data still realistic? Are there other ways to demonstrate respect when obtaining consent is not possible? Are there data governance models that can provide oversight for participant concerns or wishes?  What actions\, beyond consent\, should be taken to respect or benefit the participants who contributed their data? \n\n\n\nThis meeting is open to sponsors of the MRCT Center Bioethics Collaborative and select invited guests. For more information about the Bioethics Collaborative and how to become a sponsor\, click here.
URL:https://mrctcenter.org/tribe-events/whats-mine-is-mine-and-whats-yours-is-mine-data-ownership-and-sovereignty/
ATTACH;FMTTYPE=image/jpeg:https://mrctcenter.org/wp-content/uploads/2022/11/Bioethics2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261021T080000
DTEND;TZID=America/New_York:20261022T140000
DTSTAMP:20260926T212017
CREATED:20260701T152610Z
LAST-MODIFIED:20260926T192413Z
UID:26006-1792569600-1792677600@mrctcenter.org
SUMMARY:MRCT Center 2026 Annual Symposium
DESCRIPTION:Meeting\n\n\n\n\n\n\n\n\n\n\n\n\n\nJOIN US! MRCT Center 2026 Annual Symposium\n\n\n\nThe MRCT Center Annual Symposium returns to Boston for a full day of discussions on ethical\, actionable\, and practical solutions to today’s global clinical research challenges. Free and open to all\, in person or online. \n\n\n\nKeynote: Karim Mikhail\, Director\, Center for Biologics Evaluation and Research (CBER)\, U.S. Food and Drug Administration \n\n\n\nWe are pleased to welcome Karim Mikhail as this year’s keynote speaker. Director Mikhail will give an update on Operation TrialBlazer\, the HHS roadmap for maintaining U.S. leadership in early clinical research and development\, and the initiatives planned under it. He brings more than two decades of leadership across industry and FDA. \n\n\n\nPanel 1 | Response to Keynote: Ideation to Implementation and Scale \n\n\n\nLeaders from industry and academic medicine respond to the keynote and discuss how Operation TrialBlazer’s planned initiatives can move from roadmap to practice. \n\n\n\nPanelists: Ginny Beakes-Read\, Johnson & Johnson; Karen Hartman\, Mayo Clinic; Jennifer Sheller\, Merck \n\n\n\nModerators: Barbara Bierer\, MRCT Center; Mark Barnes\, Ropes & Gray and MRCT Center \n\n\n\nPanel 2 | Returning Summary Results to Participants: Lessons from the EU and UK Experience: Optimizing for US Application \n\n\n\nNIH has released a draft policy on sharing summary-level study results with participants\, with comments due October 26. Participant\, researcher\, and regulator voices from the EU and UK join NIH to discuss what they learned returning aggregate results\, what they would do differently\, and what they recommend for those just getting started. \n\n\n\nPanelists: Adam Berger\, U.S. National Institutes of Health; Johanna Blom\, University of Modena\, Italy; Clive Collett\, Health Research Authority\, UK; Veronica Popa\, EURORDIS \n\n\n\nModerator: Sylvia Baedorf Kassis\, MRCT Center \n\n\n\nPanel 3 | Post-Trial Obligations: An Integrated Decision Model for Clinical Trial Placement \n\n\n\nThis panel explores the circumstances that challenge trial placement\, when durable access is achievable in a host country or community\, and when reciprocal benefits are acceptable if it is not. Panelists will also discuss the MRCT Center’s draft Integrated Decision Model for Clinical Trial Placement\, developed by its Post-Trial Responsibilities Task Force to guide sponsors. \n\n\n\nPanelists: Ginny Acha\, Merck; Joseph Ali\, Johns Hopkins University; Karla Childers\, Johnson & Johnson \n\n\n\nModerator: Sarah White\, MRCT Center \n\n\n\nMRCT Center Updates \n\n\n\nSelect initiatives from across our portfolio: \n\n\n\n\nAI and the Administration of Research\n\n\n\nChildhood Cancer Academic–Industry Collaborative Platform Trials (C3PT)\n\n\n\nProportionate Oversight in Decentralized Clinical Trials\n\n\n\nTRACE\n\n\n\n\nThursday\, October 22 | Data Sharing \n\n\n\nThe second day focuses on data sharing and is co-organized with Vivli. Attend one day or both\, in person or virtually. Please click here to view the draft agenda. \n\n\n\n    \n    Register Now\n    \n\n\n\n\n\n\nAgenda\n\n\n\n2026-09-26 Annual Symposium 2-Day Agenda October 20-22\, 2026 DRAFTDownload
URL:https://mrctcenter.org/tribe-events/mrct-center-2026-annual-symposium/
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://mrctcenter.org/wp-content/uploads/2026/07/26-06-30-Annual-Symposium-Graphic_Gen-Pop.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261027T110000
DTEND;TZID=America/New_York:20261027T120000
DTSTAMP:20260926T212017
CREATED:20260828T174054Z
LAST-MODIFIED:20260909T004444Z
UID:26198-1793098800-1793102400@mrctcenter.org
SUMMARY:Returning Summary Results to Participants: Lessons from the Research Community
DESCRIPTION:This webinar will focus on returning aggregate study results to participants as a patient-focused best practice that centers health literacy. After an introduction to the newly released NIH policy\, contextualized within the global history of returning results\, the panel will feature academic researchers discussing the essential elements of sharing their findings with participants\, including why and how they do it\, and what they have learned along the way. Attendees will come away with lessons they can incorporate as they consider their own return of results processes. \n\n\n\n    \n    Register Now\n    \n\n\n\n\n\n\nDeliverables\n\n\n\n\n\n\nProjects\n\n\n\n\n\n\n\n			    October 29\, 2022 \n    Training & Education ›
URL:https://mrctcenter.org/tribe-events/returning-results-to-participants-in-practice/
LOCATION:Virtual Event
CATEGORIES:Presentations / Webinars,Webinar
ATTACH;FMTTYPE=image/png:https://mrctcenter.org/wp-content/uploads/2026/08/2026_HL-Month_Webinar-graphic_REGISTER-NOW.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261105T130000
DTEND;TZID=America/New_York:20261105T153000
DTSTAMP:20260926T212017
CREATED:20251125T173427Z
LAST-MODIFIED:20251125T173429Z
UID:25125-1793883600-1793892600@mrctcenter.org
SUMMARY:Meeting of The Research\, Development\, and Regulatory Roundtable (R3)
DESCRIPTION:The Research\, Development\, and Regulatory Roundtable (R3) is a forum to discuss pre-competitive issues in drug and device development\, regulatory oversight of clinical trials\, and human subjects research. Meetings convene policymakers\, legal counsel\, academicians\, industry representatives\, and global regulators. The R3 is a cooperative endeavor coordinated by the MRCT Center and Ropes & Gray LLP. \n\n\n\nThis hybrid meeting is open to sponsors of the Research\, Development\, and Regulatory Roundtable. \n\n\n\nTopic: TBD \n\n\n\nFor more information\, please email at MRCT@BWH.HARVARD.EDU \n\n\n\n\n\n\n\n\n\n\n\nDeliverables\n\n\n\n\n\n\nProjects\n\n\n\n\n\n\n\n			    October 29\, 2022 \n    Training & Education ›
URL:https://mrctcenter.org/tribe-events/meeting-of-the-research-development-and-regulatory-roundtable-r3-11/
LOCATION:hybrid
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/jpeg:https://mrctcenter.org/wp-content/uploads/2022/11/R3.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261201T130000
DTEND;TZID=America/New_York:20261201T150000
DTSTAMP:20260926T212017
CREATED:20260706T164726Z
LAST-MODIFIED:20260713T202508Z
UID:25905-1796130000-1796137200@mrctcenter.org
SUMMARY:Joint Task Force for Clinical Trial Competency (JTF) Global Biannual Meeting
DESCRIPTION:Meeting\n\n\n\n\n\n\n\n\n\n\n\n\n\nThe Joint Task Force for Clinical Trial Competency (JTF)\, anchored at the MRCT Center\, develops and disseminates standards and practices for the global clinical research workforce. By fostering a cohesive and collaborative approach\, the JTF ensures that professionals have the competencies to conduct clinical trials ethically and effectively. \n\n\n\nOur international team of investigators\, educators\, and clinical research professionals has developed and/or utilizes a framework that defines the knowledge\, skills\, and attitudes necessary for conducting safe\, ethical\, and high-quality clinical research. \n\n\n\nJoin us on December 1\, 2026\, 1:00-3:00 PM for the Joint Task Force for Clinical Trial Competency (JTF) Biannual Global Meeting to hear about global perspectives on implementing the JTF Framework.  \n\n\n\nTo learn more about the JTF Framework: https://mrctcenter.org/clinical-trial-competency/framework/overview/ \n\n\n\nAll registrants will receive slides and a meeting summary after the meeting. This event is free.  \n\n\n\n    \n    REGISTER HERE
URL:https://mrctcenter.org/tribe-events/joint-task-force-for-clinical-trial-competency-jtf-global-biannual-meeting-6/
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://mrctcenter.org/wp-content/uploads/2025/07/2025-12_Biannual-Global-Meeting_JTF_Graphic-06.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261208T100000
DTEND;TZID=America/New_York:20261208T123000
DTSTAMP:20260926T212017
CREATED:20260409T145109Z
LAST-MODIFIED:20260409T145404Z
UID:25707-1796724000-1796733000@mrctcenter.org
SUMMARY:Meeting of the Bioethics Collaborative
DESCRIPTION:Topic: TBD \n\n\n\nThis meeting is open to sponsors of the MRCT Center Bioethics Collaborative and select invited guests. For more information about the Bioethics Collaborative and how to become a sponsor\, click here.
URL:https://mrctcenter.org/tribe-events/meeting-of-the-bioethics-collaborative-december-8-2026/
ATTACH;FMTTYPE=image/png:https://mrctcenter.org/wp-content/uploads/2022/12/bioethics-1.png
END:VEVENT
END:VCALENDAR